Minimum incision endoscopic radical cystectomy in patients with malignant tumors of the urinary bladder: clinical and oncological outcomes at a single institution

Eur J Surg Oncol. 2012 Nov;38(11):1101-5. doi: 10.1016/j.ejso.2012.07.115. Epub 2012 Aug 3.


Aims: The objectives of this study were to investigate the clinical and oncological outcomes of patients with malignant tumors of the urinary bladder undergoing minimum incision endoscopic radical cystectomy (MIE-RC).

Methods: Between August 2005 and June 2011, 130 consecutive patients at Hirosaki University Hospital underwent MIE-RC and bilateral lymphadenectomy for malignant tumors of the urinary bladder. We retrospectively studied all 130 patients. MIE-RC was performed through a 7-cm suprapubic midline incision. A 30° laparoscope was conveniently positioned on the head side of the patients, for precise observation and monitoring.

Results: The median operative time for all procedures, including MIE-RC, bilateral pelvic lymphadenectomy and urinary diversion was 266 min. The median estimated blood loss was 1260 mL. None of the patients had positive surgical margins. The post-operative median follow-up period was 32.8 months. The 5-year overall and disease-free survival rates were 91.6% and 87.0%, respectively.

Conclusions: Our experience with MIE-RC appears to be favorable with acceptable operative and oncological outcomes.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cystectomy / adverse effects
  • Cystectomy / methods*
  • Disease-Free Survival
  • Female
  • Humans
  • Laparoscopy / methods*
  • Lymph Node Excision
  • Male
  • Middle Aged
  • Survival Rate
  • Urinary Bladder Neoplasms / mortality
  • Urinary Bladder Neoplasms / surgery*
  • Urinary Diversion